Pranil K. Chandra, DO, FCAP, FASCP
Chief Medical Officer of Genomic
and Clinical Pathology
PathGroup
Brentwood, TN
Pranil K. Chandra, DO, FCAP, FASCP
Dr. Chandra joined PathGroup in 2011 as Associate Medical Director of Molecular Pathology and now currently serves as Chief Medical Officer of Genomic and Clinical Pathology Services at PathGroup. Dr. Chandra holds board certifications in anatomic and clinical pathology, hematopathology, and molecular genetic pathology. He completed his AP/CP training and fellowships in hematopathology, oncologic pathology, and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center, respectively. While at MD Anderson, Dr. Chandra served as Chief Fellow and received numerous awards for his research in acute myeloid leukemia. He has presented numerous abstracts and platform presentations at various pathology meetings and has published peer-reviewed articles and book chapters. Dr. Chandra is a member of the American Society of Clinical Pathology, Association of Molecular Pathology, where he also serves in a leadership capacity to the Economic Affairs and Clinical Practice Committees. Dr. Chandra is a medical consultant in molecular pathology and personalized medicine and is considered a national thought leader in precision medicine and cancer genomics.
Michael Clare-Salzler, MD
Dr. Clare-Salzler received his medical degree and internal medicine training from the State University of New York at Buffalo. He began his clinical endocrinology and immunology research career at the University of California in Los Angeles, where he studied the immunopathogenesis of type 1 diabetes. Dr. Clare-Salzler maintains an active practice in endocrinology, treating patients with diabetes and other endocrine diseases as well as an active research program. He has also played a leadership role in the development of the clinical molecular pathology laboratory and the Precision Medicine program at the University of Florida School of Medicine.
Michael Clare-Salzler, MD
Chair of Pathology
University of Florida School of Medicine
Gainesville, FL
James M. Crawford, MD, PhD
Professor and Chair, Pathology and Laboratory Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Great Neck, Hempstead, NY
James M. Crawford, MD, PhD
Dr. Crawford oversees the integrated laboratory network for Northwell Health, which includes 23 hospital-based clinical laboratories; the health system’s integrated pathology practice; and the centralized Core Laboratory that serves Northwell and, through the CLNY Alliance, the 15 hospitals of Health + Hospitals of New York City.
Dr. Crawford is a leading proponent of the role of pathology and the clinical laboratory industry in patient-centered care and value-based care. He provides national leadership in developing the value statements for laboratory diagnostic services, which includes being a founding member of Project Santa Fe and the concept of “Clinical Laboratory 2.0.” The latter’s goal is for clinical laboratories to support a proactive, integrative paradigm of health care, taking particular advantage of the vast store of latent information in the data routinely generated through clinical laboratories. This is then coupled with opportunities in precision medicine, as through genomics, biobanking, and informatics.
Author of more than 260 publications, Dr. Crawford is editor-in-chief of Academic Pathology, the official journal of the Association of Pathology Chairs (APC). He received his MD and PhD from Duke University School of Medicine, and he completed post-graduate training in anatomic pathology and gastrointestinal pathology at Brigham and Women's Hospital, followed by a fellowship in hepatic pathology at the Royal Free Hospital in London.
Jordan Seth Laser, MD
Dr. Laser is a board-certified anatomic, clinical, and molecular genetic pathologist. Currently employed at Northwell Health System in New York, Dr. Jordan serves the Department of Pathology and Laboratory Medicine in the following roles: Medical Director, LIJ Pathology and Laboratory Medicine; Associate Medical Director, Core Laboratories; Senior Director, Division of Cytogenetics and Molecular Pathology; and Director, Division of Near Patient Testing. His expertise includes molecular and genomic medicine, laboratory management, healthcare finance, and standards and regulations.
Jordan Seth Laser, MD
Associate Professor
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Member, College of American Pathology Personalized Medicine Committee
New Hyde Park, NY
Elke Nelson-Nichols, PhD, MBA
Director of Research Strategy and Operations
Tempus Labs
Chicago, IL